Recurrent tuberculosis: Relapse or reinfection?;La tubercolosi ricorrente: Recidiva o reinfezione esogena?

Infezioni in Medicina

Volumn 21, Issue 4, 2013, Pages 251-260

  Schiroli, Consuelo ^a   Franzetti, Fabio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Exogenous reinfection; HIV infection; Recurrences; Relapse; Tuberculosis

Indexed keywords

COMORBIDITY; DISEASE ERADICATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; INCIDENCE; META ANALYSIS (TOPIC); POSTPRIMARY TUBERCULOSIS; RECURRENCE RISK; RELAPSE; REVIEW; TUBERCULOSIS; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROBIOLOGY; RECURRENT DISEASE; RISK FACTOR;

HIV INFECTIONS; HUMANS; RECURRENCE; RISK FACTORS; TUBERCULOSIS;

EID: 84891592305     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Dias H.M, Falzon D., Fitzpatrick C., et al. Global Tuberculosis Control WHO 2012, WF 300.
2. Morandi M., D'Amato S., Fattorini L., et al. Rapporto. La Tubercolosi in Italia. Anno 2008. 2010. Disponibile in rete all'indirizzo http://www.salute.gov.it/imgs/C_17_pubblicazioni_1222_allegato.pdf
3. Verver S., Warren R.M., Beyers N., et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am. J. Respir. Crit. Care Med. 171, 1430-1435, 2005.
4. van Rie A., Warren R., Richardson M. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment N. Engl J. Med. 341, 1174-1179, 1999.
5. Panjabi R., Comstock G.W., Golub J.E. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int. J. Tuberc. Lung Dis. 11, 8, 828-837, 2007.
6. Lambert M.L., Hasker E., Van Deun A., Roberfroid D., Boelaert M., Van der Stuyft P. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect. Dis. 3, 282-287, 2003.
7. Narayanan S., Swaminathan S., Supply P., et al. Impact of HIV infection on the recurrence of tuberculosis in South India. J. Infect. Dis. 201, 691-703, 2010.
8. Chiang C.Y., Riley L.W. Exogenous reinfection in tuberculosis. Lancet Infect. Dis. 5, 629-636, 2005.
9. Warren R.M., Victor T.C., Streicher E.M., et al. Patients with active tuberculosis often have different strains in the same sputum specimen, Am. J. Respir. Crit. Care Med. 169, 610-614, 2004.
10. Martín A., Herranz M., Navarro Y., et al. Evaluation of the inaccurate assignment of mixed infections by Mycobacterium tuberculosis as exogenous reinfection and analysis of the potential role of bacterial factors in reinfection. J. Clin. Microbiol. 49, 4, 1331-1338, 2011.
11. van Embden J. D., Cave M. D., Crawford J. T., et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31, 2, 406-409, 1993.
12. Supply P., Mazars E., Lesjean S., Vincent V., Gicquel B., Locht C. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Molecular Microbiology 36, 3, 762-771, 2000.
13. Centre for Disease Prevention and Control (ECDC), WHO Regional Office for Europe (WHO/Europe). Tuberculosis Surveillance and Monitoring in Europe. Report 2012, ISSN 1977-3986.
14. Das S., Chan S.L., Allen B.W., Mitchison D.A., Lowrie D.B. Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tuberc. Lung Dis. 74, 1, 4751, 1993.
15. Verver S., Warren R.M., Munch Z., et al. Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet 17, 363, 9404, 212-214, 2004.
16. Sonnenberg P., Murray J., Glynn J. R., Shearer S., Kambashi B., Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in south African mineworkers. Lancet 358, 1687-1693, 2001.
17. Shen G., Xue Z., Shen X., et al. Recurrent tuberculosis and exogenous reinfection Shanghai, China. Emerg. Infect. Dis. 12, 1777-1778, 2006.
18. Mallory K. F., Churchyard G. J., Kleinschmidt I., De Cock K. M., Corbett E. L. The impact of HIV infection on recurrence of tuberculosis in South African gold miners. Int. J. Tuberc. Lung Dis. 4, 5, 455-462, 2000.
19. Charalambous S., Grant A.D., Moloi V., et al. Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int. J. Tuberc. Lung Dis. 12, 8, 942-948, 2008.
20. Glynn J.R., Murray J., Bester A., Nelson G., Shearer S., Sonnenberg P. High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis. J. Infect. Dis. 201, 704-711, 2010.
21. Crampin A. C., Mwaungulu J.N., Mwaungulu F.D., et al. Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS, 24, 3, 417-426, 2010.
22. Golub J.E., Durovni B., King B.S., et al. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 22, 18, 2527-2533, 2008.
23. Picon P.D., Bassanesi S.L., Avancini Caramori M.L., Targa Ferreira R.L., Jarczewski C.A., de Borba Vieira P.R. Risk factors for recurrence of tuberculosis. J. Bras. Pneumol. 33, 5, 572-578, 2007.
24. Jasmer R.M., Bozeman L., Schwartzman K., et al. Recurrent tuberculosis in the United States and Canada. Am. J. Respir. Crit. Care Med. 170, 1360-1366, 2004.
25. Bang D., Andersen A.B., Thomsen V.O., Lillebaek T. Recurrent tuberculosis in Denmark: relapse vs re-infection. Int J. Tuberc. Lung Dis. 14, 4, 447-453, 2010.
26. Luzze H., Johnson D.F, Dickman K., et al. Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda. Int J. Tuberc. Lung Dis. 17, 3, 361-367, 2013.
27. El Sahly H.M., Wright J.A., Soini H., et al. Recurrent tuberculosis in Houston, Texas: a population-based study. Int. J. Tuberc. Lung Dis. 8, 3, 333-340, 2004.
28. Garcia de Viedma D., Marin M., Hernangomez S., et al. Tuberculosis Recurrences-Reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection. Arch. Intern. Med. 162, 1873-1879, 2002.
29. Garcia Ordonez M.A., Martinez Gonzales J., Orihuela Canadas F., Jimenez Onate y F., Colmenero Castillo J. D. Tuberculosis recurrente en paziente coinfectados por VIH. REV. Clin. Esp. 203, 6, 279-283, 2003.
30. Hung C.C., Hsiao C.F. Recurrence of tuberculosis in HIV-1-infected adults treated after rifamycin-based treatment and highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 34, 4, 437-438, 2003.
31. Bandera A., Gori A., Catozzi L., et al. Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J. Clin. Microbiol. 39, 6, 2213-2218, 2001.
32. Johnson J.L., Okwera A., Nsubuga P., et al. Efficacy of an unsupervised 8-month rifampicin-containg regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Int. J. Tuberc. Lung Dis. 4, 11, 1032-1040, 2000.
33. Fatkenheuer G., Taelman H., Lepage P., Schwenk A., Wenzel R. The return of tuberculosis. Diagn. Microbiol. Infect. Dis. 34, 139-146, 1999.
34. Caminero J.A., Pena M.J., Campos-Herrero M.I., et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am. J. Respir. Crit. Care. Med. 163, 717-720, 2001.
35. Blumberg H.M., Burman W.J., Chaisson R.E., et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am. J. Respir. Crit. Care Med. 167, 4, 603-662, 2003.
36. Fitzgerald D.W., Desvarieux M., Severe P., Joseph P., Johnson W.D. Jr, Pape J.W. Effect of posttreatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet 356, 9240, 1470-1474, 2000.
37. Churchyard G.J., Fielding K., Charalambous S., et al. Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? AIDS 17, 14, 2063-2070, 2003.
38. Lienhardt C., Glaziou P., Uplekar M., Lönnroth K., Getahun H., Raviglione M. Global tuberculosis control: lessons learnt and future prospects. Nat. Rev. Microbiol. 10, 6, 407-416, 2012.
39. Barnard M., Albert H., Coetzee G., O'Brien R., Bosman M.E. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177, 7, 787-792, 2008.